Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Protein Networks02:26

Protein Networks

4.2K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Tumor Progression02:07

Tumor Progression

6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Structure to Function and Back Again: A GAN-Guided Diffusion Framework for Generating Clinically Meaningful Multimodal Neuroimaging Data.

Research square·2026
Same author

Monocular Markerless Motion Capture Enables Quantitative Assessment of Upper Extremity Reachable Workspace.

Sensors (Basel, Switzerland)·2026
Same author

Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers.

IEEE transactions on bio-medical engineering·2026
Same author

Multi-level Asymmetric Contrastive Learning for Medical Image Segmentation Pre-training.

IEEE journal of biomedical and health informatics·2026
Same author

BMRetriever: Tuning Large Language Models as Better Biomedical Text Retrievers.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same author

Knowledge-Infused Prompting: Assessing and Advancing Clinical Text Data Generation with Large Language Models.

Findings of ACL. ACL·2026

Related Experiment Video

Updated: Oct 26, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K

An Integrated Deep Network for Cancer Survival Prediction Using Omics Data.

Hamid Reza Hassanzadeh1, May D Wang2

  • 1School of Interactive Computing, Georgia Institute of Technology, Atlanta, GA, United States.

Frontiers in Big Data
|August 2, 2021
PubMed
Summary

This study introduces an integrated deep belief network for cancer survival prediction. The novel approach effectively stratifies high-risk cancer patients using multi-omics data, even with moderate dataset sizes.

Keywords:
RNA-seqdeep belief networksdeep learningintegrated cancer survival analysismulti-omicsprecision medicine

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 26, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Cancer involves complex cellular dysregulation across multiple levels.
  • Precision medicine requires patient stratification based on molecular profiles for tailored treatments.

Purpose of the Study:

  • To develop an integrated deep belief network for differentiating high-risk from low-risk cancer patients based on overall survival.
  • To leverage multi-omics data (RNA, miRNA, methylation) for cancer survival prediction and risk stratification.

Main Methods:

  • Utilized an integrated deep belief network model.
  • Analyzed RNA, miRNA, and methylation data from labeled and unlabeled samples.
  • Applied the model to datasets from three cancer types (836 patients).

Main Results:

  • The integrated deep belief network outperformed existing supervised and semi-supervised classification techniques.
  • Demonstrated effective cancer survival prediction and risk stratification.
  • Achieved superior results on moderately sized cancer datasets, challenging deep learning preconceptions.

Conclusions:

  • The proposed integrative analytics framework provides a robust method for cancer patient risk stratification.
  • The deep belief network model offers a promising tool for precision oncology, particularly with limited data.
  • This approach enhances the potential for personalized cancer treatment strategies.